Health care: the measure of a robust system

13 October 2017 - For all its faults, for all the times that things don’t go as planned, Australia’s health system ...

Read more →

Annual performance statistics report: July 2016 to June 2017

12 September 2017 - Since the 2015-16 report, the number of submissions received across some Category 1 application types varied significantly.  ...

Read more →

TGA key performance indicators: July 2015 to June 2016

14 November 2016 - The TGA has published a self-assessed rating of its overall performance for the year ending 30 ...

Read more →

2015: another strong year for patients in need of new drug therapies

4 January 2016 - In 2015, FDA’s CDER approved 45 novel new therapies – significantly more than the average of 28 ...

Read more →

No evidence that £1bn Cancer Drugs Fund has helped patients, says watchdog

17 September 2015 - There is no way of knowing whether the Cancer Drugs Fund, which has cost the NHS £1bn ...

Read more →

CDF has improved drugs access but is not sustainable, NAO finds

17 September 2015 - England’s Cancer Drug Fund has improved patient access to novel cancer drugs not routinely available on the ...

Read more →

Smart buys and PBS shift pay off for Sigma

11 September 2015 - Sigma Pharmaceuticals boss Mark Hooper says the business is in a “good position”, flagging earnings growth on ...

Read more →

TGA key performance indicators: January to June 2015

3 September 2015 - The performance of the TGA is measured through eight key performance indicators (KPIs): ...

Read more →